Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Gastrointestinal Cancers Congress 2024

EORTC session: Hot topics and methodological perspectives in GI oncology trials

Here we are again: Bevacizumab or anti-EGFR monoclonal antibodies for upfront unresectable, left-sided, colorectal cancer liver metastases? Pro bevacizumab

Date

27 Jun 2024

Session

EORTC session: Hot topics and methodological perspectives in GI oncology trials

Topics

Targeted Therapy

Tumour Site

Colon and Rectal Cancer

Presenters

Francesco Sclafani

Authors

F. Sclafani

Author affiliations

  • Institute Jules Bordet, Brussels/BE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.